nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Cytochrome P450 2C19 Inhibitors—Topiramate—obesity	0.514	0.55	CiPCiCtD
Oritavancin—Cytochrome P450 3A4 Inducers—Topiramate—obesity	0.42	0.45	CiPCiCtD
Oritavancin—Allergic cutaneous angiitis—Cimetidine—obesity	0.0042	0.0635	CcSEcCtD
Oritavancin—Leukocytoclastic vasculitis—Cimetidine—obesity	0.00272	0.0411	CcSEcCtD
Oritavancin—Tenosynovitis—Sibutramine—obesity	0.00214	0.0323	CcSEcCtD
Oritavancin—Abscess—Sibutramine—obesity	0.000902	0.0136	CcSEcCtD
Oritavancin—Cellulitis—Sibutramine—obesity	0.000785	0.0119	CcSEcCtD
Oritavancin—Tachycardia—Methamphetamine—obesity	0.000782	0.0118	CcSEcCtD
Oritavancin—Hyperuricaemia—Sibutramine—obesity	0.00077	0.0116	CcSEcCtD
Oritavancin—Tachycardia—Benzphetamine—obesity	0.000754	0.0114	CcSEcCtD
Oritavancin—Blood uric acid increased—Sibutramine—obesity	0.000727	0.011	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Methamphetamine—obesity	0.000692	0.0105	CcSEcCtD
Oritavancin—Tachycardia—Phendimetrazine—obesity	0.000688	0.0104	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Benzphetamine—obesity	0.000667	0.0101	CcSEcCtD
Oritavancin—Urticaria—Methamphetamine—obesity	0.000637	0.00962	CcSEcCtD
Oritavancin—Erythema multiforme—Cimetidine—obesity	0.000634	0.00958	CcSEcCtD
Oritavancin—Urticaria—Benzphetamine—obesity	0.000614	0.00927	CcSEcCtD
Oritavancin—Wheezing—Bupropion—obesity	0.000604	0.00913	CcSEcCtD
Oritavancin—Hypersensitivity—Methamphetamine—obesity	0.000591	0.00892	CcSEcCtD
Oritavancin—Tachycardia—Phenylpropanolamine—obesity	0.000587	0.00887	CcSEcCtD
Oritavancin—Hypersensitivity—Benzphetamine—obesity	0.000569	0.0086	CcSEcCtD
Oritavancin—Tachycardia—Phentermine—obesity	0.000562	0.00849	CcSEcCtD
Oritavancin—Hypoglycaemia—Orlistat—obesity	0.000549	0.00829	CcSEcCtD
Oritavancin—Diarrhoea—Methamphetamine—obesity	0.000548	0.00828	CcSEcCtD
Oritavancin—Hypoglycaemia—Sibutramine—obesity	0.000531	0.00802	CcSEcCtD
Oritavancin—Dizziness—Methamphetamine—obesity	0.00053	0.008	CcSEcCtD
Oritavancin—Diarrhoea—Benzphetamine—obesity	0.000529	0.00799	CcSEcCtD
Oritavancin—Myalgia—Diethylpropion—obesity	0.000523	0.00789	CcSEcCtD
Oritavancin—Dizziness—Benzphetamine—obesity	0.000511	0.00772	CcSEcCtD
Oritavancin—Headache—Methamphetamine—obesity	0.000502	0.00758	CcSEcCtD
Oritavancin—Myalgia—Cimetidine—obesity	0.000497	0.00751	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Phentermine—obesity	0.000497	0.00751	CcSEcCtD
Oritavancin—Tachycardia—Diethylpropion—obesity	0.000489	0.00738	CcSEcCtD
Oritavancin—Headache—Benzphetamine—obesity	0.000484	0.00731	CcSEcCtD
Oritavancin—Diarrhoea—Phendimetrazine—obesity	0.000482	0.00728	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Sibutramine—obesity	0.000467	0.00705	CcSEcCtD
Oritavancin—Dizziness—Phendimetrazine—obesity	0.000466	0.00704	CcSEcCtD
Oritavancin—Tachycardia—Cimetidine—obesity	0.000465	0.00703	CcSEcCtD
Oritavancin—Hypoglycaemia—Bupropion—obesity	0.000463	0.00699	CcSEcCtD
Oritavancin—Nausea—Benzphetamine—obesity	0.000459	0.00693	CcSEcCtD
Oritavancin—Urticaria—Phentermine—obesity	0.000457	0.00691	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Sibutramine—obesity	0.000457	0.0069	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Diethylpropion—obesity	0.000456	0.00689	CcSEcCtD
Oritavancin—Bronchospasm—Orlistat—obesity	0.000455	0.00687	CcSEcCtD
Oritavancin—Eosinophilia—Sibutramine—obesity	0.000443	0.0067	CcSEcCtD
Oritavancin—Hypersensitivity—Phenylpropanolamine—obesity	0.000443	0.0067	CcSEcCtD
Oritavancin—Headache—Phendimetrazine—obesity	0.000441	0.00666	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Cimetidine—obesity	0.000434	0.00656	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Diethylpropion—obesity	0.000432	0.00653	CcSEcCtD
Oritavancin—Nausea—Phendimetrazine—obesity	0.000418	0.00632	CcSEcCtD
Oritavancin—Infestation NOS—Orlistat—obesity	0.000413	0.00623	CcSEcCtD
Oritavancin—Infestation—Orlistat—obesity	0.000413	0.00623	CcSEcCtD
Oritavancin—Urticaria—Diethylpropion—obesity	0.000398	0.00601	CcSEcCtD
Oritavancin—Dizziness—Phenylpropanolamine—obesity	0.000398	0.00601	CcSEcCtD
Oritavancin—Diarrhoea—Phentermine—obesity	0.000394	0.00595	CcSEcCtD
Oritavancin—Bronchospasm—Bupropion—obesity	0.000384	0.0058	CcSEcCtD
Oritavancin—Vomiting—Phenylpropanolamine—obesity	0.000383	0.00578	CcSEcCtD
Oritavancin—Dizziness—Phentermine—obesity	0.000381	0.00575	CcSEcCtD
Oritavancin—Rash—Phenylpropanolamine—obesity	0.000379	0.00573	CcSEcCtD
Oritavancin—Dermatitis—Phenylpropanolamine—obesity	0.000379	0.00572	CcSEcCtD
Oritavancin—Vomiting—Phentermine—obesity	0.000366	0.00553	CcSEcCtD
Oritavancin—Oedema peripheral—Orlistat—obesity	0.000365	0.00551	CcSEcCtD
Oritavancin—Rash—Phentermine—obesity	0.000363	0.00548	CcSEcCtD
Oritavancin—Dermatitis—Phentermine—obesity	0.000363	0.00548	CcSEcCtD
Oritavancin—Headache—Phentermine—obesity	0.000361	0.00545	CcSEcCtD
Oritavancin—Nausea—Phenylpropanolamine—obesity	0.000357	0.0054	CcSEcCtD
Oritavancin—Oedema peripheral—Sibutramine—obesity	0.000353	0.00533	CcSEcCtD
Oritavancin—Hypersensitivity—Cimetidine—obesity	0.000351	0.0053	CcSEcCtD
Oritavancin—Infestation—Bupropion—obesity	0.000348	0.00526	CcSEcCtD
Oritavancin—Infestation NOS—Bupropion—obesity	0.000348	0.00526	CcSEcCtD
Oritavancin—Diarrhoea—Diethylpropion—obesity	0.000343	0.00518	CcSEcCtD
Oritavancin—Nausea—Phentermine—obesity	0.000342	0.00517	CcSEcCtD
Oritavancin—Immune system disorder—Orlistat—obesity	0.000335	0.00505	CcSEcCtD
Oritavancin—Mediastinal disorder—Orlistat—obesity	0.000334	0.00504	CcSEcCtD
Oritavancin—Dizziness—Diethylpropion—obesity	0.000331	0.005	CcSEcCtD
Oritavancin—Diarrhoea—Cimetidine—obesity	0.000326	0.00493	CcSEcCtD
Oritavancin—Immune system disorder—Sibutramine—obesity	0.000324	0.00489	CcSEcCtD
Oritavancin—Malnutrition—Orlistat—obesity	0.000322	0.00487	CcSEcCtD
Oritavancin—Vomiting—Diethylpropion—obesity	0.000319	0.00481	CcSEcCtD
Oritavancin—Rash—Diethylpropion—obesity	0.000316	0.00477	CcSEcCtD
Oritavancin—Dermatitis—Diethylpropion—obesity	0.000316	0.00477	CcSEcCtD
Oritavancin—Dizziness—Cimetidine—obesity	0.000315	0.00476	CcSEcCtD
Oritavancin—Headache—Diethylpropion—obesity	0.000314	0.00474	CcSEcCtD
Oritavancin—Malnutrition—Sibutramine—obesity	0.000312	0.00471	CcSEcCtD
Oritavancin—Oedema peripheral—Bupropion—obesity	0.000308	0.00465	CcSEcCtD
Oritavancin—Connective tissue disorder—Bupropion—obesity	0.000307	0.00464	CcSEcCtD
Oritavancin—Vomiting—Cimetidine—obesity	0.000303	0.00458	CcSEcCtD
Oritavancin—Rash—Cimetidine—obesity	0.000301	0.00454	CcSEcCtD
Oritavancin—Dermatitis—Cimetidine—obesity	0.0003	0.00453	CcSEcCtD
Oritavancin—Headache—Cimetidine—obesity	0.000299	0.00451	CcSEcCtD
Oritavancin—Nausea—Diethylpropion—obesity	0.000298	0.00449	CcSEcCtD
Oritavancin—Erythema multiforme—Bupropion—obesity	0.000295	0.00446	CcSEcCtD
Oritavancin—Hypoglycaemia—Topiramate—obesity	0.000295	0.00445	CcSEcCtD
Oritavancin—Angioedema—Orlistat—obesity	0.000295	0.00445	CcSEcCtD
Oritavancin—Cardiac disorder—Bupropion—obesity	0.00029	0.00438	CcSEcCtD
Oritavancin—Anaemia—Sibutramine—obesity	0.000288	0.00436	CcSEcCtD
Oritavancin—Angioedema—Sibutramine—obesity	0.000285	0.00431	CcSEcCtD
Oritavancin—Nausea—Cimetidine—obesity	0.000283	0.00428	CcSEcCtD
Oritavancin—Immune system disorder—Bupropion—obesity	0.000282	0.00426	CcSEcCtD
Oritavancin—Mediastinal disorder—Bupropion—obesity	0.000282	0.00425	CcSEcCtD
Oritavancin—Myalgia—Orlistat—obesity	0.000275	0.00415	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000273	0.00412	CcSEcCtD
Oritavancin—Malnutrition—Bupropion—obesity	0.000272	0.00411	CcSEcCtD
Oritavancin—Myalgia—Sibutramine—obesity	0.000266	0.00401	CcSEcCtD
Oritavancin—Infection—Orlistat—obesity	0.000261	0.00395	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Topiramate—obesity	0.000259	0.00391	CcSEcCtD
Oritavancin—Nervous system disorder—Orlistat—obesity	0.000258	0.0039	CcSEcCtD
Oritavancin—Skin disorder—Orlistat—obesity	0.000256	0.00386	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Topiramate—obesity	0.000254	0.00383	CcSEcCtD
Oritavancin—Infection—Sibutramine—obesity	0.000253	0.00382	CcSEcCtD
Oritavancin—Anaemia—Bupropion—obesity	0.000251	0.0038	CcSEcCtD
Oritavancin—Angioedema—Bupropion—obesity	0.000249	0.00375	CcSEcCtD
Oritavancin—Tachycardia—Sibutramine—obesity	0.000249	0.00375	CcSEcCtD
Oritavancin—Skin disorder—Sibutramine—obesity	0.000247	0.00374	CcSEcCtD
Oritavancin—Eosinophilia—Topiramate—obesity	0.000246	0.00372	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Orlistat—obesity	0.00024	0.00362	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Sibutramine—obesity	0.000232	0.0035	CcSEcCtD
Oritavancin—Myalgia—Bupropion—obesity	0.000232	0.0035	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00023	0.00347	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Orlistat—obesity	0.000227	0.00343	CcSEcCtD
Oritavancin—Infestation NOS—Topiramate—obesity	0.000222	0.00335	CcSEcCtD
Oritavancin—Infestation—Topiramate—obesity	0.000222	0.00335	CcSEcCtD
Oritavancin—Infection—Bupropion—obesity	0.000221	0.00333	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Sibutramine—obesity	0.00022	0.00332	CcSEcCtD
Oritavancin—Nervous system disorder—Bupropion—obesity	0.000218	0.00329	CcSEcCtD
Oritavancin—Tachycardia—Bupropion—obesity	0.000217	0.00327	CcSEcCtD
Oritavancin—Skin disorder—Bupropion—obesity	0.000216	0.00326	CcSEcCtD
Oritavancin—Urticaria—Orlistat—obesity	0.000209	0.00316	CcSEcCtD
Oritavancin—Urticaria—Sibutramine—obesity	0.000202	0.00306	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Bupropion—obesity	0.000202	0.00305	CcSEcCtD
Oritavancin—Oedema peripheral—Topiramate—obesity	0.000196	0.00296	CcSEcCtD
Oritavancin—Connective tissue disorder—Topiramate—obesity	0.000196	0.00295	CcSEcCtD
Oritavancin—Hypersensitivity—Orlistat—obesity	0.000194	0.00293	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Bupropion—obesity	0.000192	0.00289	CcSEcCtD
Oritavancin—Erythema multiforme—Topiramate—obesity	0.000188	0.00284	CcSEcCtD
Oritavancin—Hypersensitivity—Sibutramine—obesity	0.000188	0.00283	CcSEcCtD
Oritavancin—Pruritus—Orlistat—obesity	0.000186	0.00281	CcSEcCtD
Oritavancin—Cardiac disorder—Topiramate—obesity	0.000185	0.00279	CcSEcCtD
Oritavancin—Pruritus—Sibutramine—obesity	0.00018	0.00272	CcSEcCtD
Oritavancin—Diarrhoea—Orlistat—obesity	0.00018	0.00272	CcSEcCtD
Oritavancin—Immune system disorder—Topiramate—obesity	0.00018	0.00272	CcSEcCtD
Oritavancin—Mediastinal disorder—Topiramate—obesity	0.000179	0.00271	CcSEcCtD
Oritavancin—Urticaria—Bupropion—obesity	0.000176	0.00266	CcSEcCtD
Oritavancin—Diarrhoea—Sibutramine—obesity	0.000174	0.00263	CcSEcCtD
Oritavancin—Dizziness—Orlistat—obesity	0.000174	0.00263	CcSEcCtD
Oritavancin—Malnutrition—Topiramate—obesity	0.000173	0.00262	CcSEcCtD
Oritavancin—Dizziness—Sibutramine—obesity	0.000168	0.00254	CcSEcCtD
Oritavancin—Vomiting—Orlistat—obesity	0.000167	0.00253	CcSEcCtD
Oritavancin—Rash—Orlistat—obesity	0.000166	0.00251	CcSEcCtD
Oritavancin—Dermatitis—Orlistat—obesity	0.000166	0.0025	CcSEcCtD
Oritavancin—Headache—Orlistat—obesity	0.000165	0.00249	CcSEcCtD
Oritavancin—Hypersensitivity—Bupropion—obesity	0.000164	0.00247	CcSEcCtD
Oritavancin—Vomiting—Sibutramine—obesity	0.000162	0.00245	CcSEcCtD
Oritavancin—Rash—Sibutramine—obesity	0.000161	0.00243	CcSEcCtD
Oritavancin—Dermatitis—Sibutramine—obesity	0.00016	0.00242	CcSEcCtD
Oritavancin—Anaemia—Topiramate—obesity	0.00016	0.00242	CcSEcCtD
Oritavancin—Headache—Sibutramine—obesity	0.00016	0.00241	CcSEcCtD
Oritavancin—Pruritus—Bupropion—obesity	0.000157	0.00237	CcSEcCtD
Oritavancin—Nausea—Orlistat—obesity	0.000156	0.00236	CcSEcCtD
Oritavancin—Diarrhoea—Bupropion—obesity	0.000152	0.00229	CcSEcCtD
Oritavancin—Nausea—Sibutramine—obesity	0.000151	0.00228	CcSEcCtD
Oritavancin—Myalgia—Topiramate—obesity	0.000148	0.00223	CcSEcCtD
Oritavancin—Dizziness—Bupropion—obesity	0.000147	0.00222	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000147	0.00221	CcSEcCtD
Oritavancin—Vomiting—Bupropion—obesity	0.000141	0.00213	CcSEcCtD
Oritavancin—Infection—Topiramate—obesity	0.000141	0.00212	CcSEcCtD
Oritavancin—Rash—Bupropion—obesity	0.00014	0.00211	CcSEcCtD
Oritavancin—Dermatitis—Bupropion—obesity	0.00014	0.00211	CcSEcCtD
Oritavancin—Headache—Bupropion—obesity	0.000139	0.0021	CcSEcCtD
Oritavancin—Nervous system disorder—Topiramate—obesity	0.000139	0.00209	CcSEcCtD
Oritavancin—Tachycardia—Topiramate—obesity	0.000138	0.00208	CcSEcCtD
Oritavancin—Skin disorder—Topiramate—obesity	0.000137	0.00208	CcSEcCtD
Oritavancin—Nausea—Bupropion—obesity	0.000132	0.00199	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Topiramate—obesity	0.000129	0.00195	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Topiramate—obesity	0.000122	0.00184	CcSEcCtD
Oritavancin—Urticaria—Topiramate—obesity	0.000112	0.0017	CcSEcCtD
Oritavancin—Hypersensitivity—Topiramate—obesity	0.000104	0.00157	CcSEcCtD
Oritavancin—Pruritus—Topiramate—obesity	0.0001	0.00151	CcSEcCtD
Oritavancin—Diarrhoea—Topiramate—obesity	9.68e-05	0.00146	CcSEcCtD
Oritavancin—Dizziness—Topiramate—obesity	9.35e-05	0.00141	CcSEcCtD
Oritavancin—Vomiting—Topiramate—obesity	8.99e-05	0.00136	CcSEcCtD
Oritavancin—Rash—Topiramate—obesity	8.92e-05	0.00135	CcSEcCtD
Oritavancin—Dermatitis—Topiramate—obesity	8.91e-05	0.00135	CcSEcCtD
Oritavancin—Headache—Topiramate—obesity	8.86e-05	0.00134	CcSEcCtD
Oritavancin—Nausea—Topiramate—obesity	8.4e-05	0.00127	CcSEcCtD
